MarketAnalysis市场分析
NASDAQGS:GILD

Gilead Sciences, Inc. - NASDAQGS:GILD - Comprehensive analysis

Free evaluation through quantitative algorithms Gilead Sciences, Inc. - NASDAQGS:GILD

Quant Rating

1

Strong Sell

2

Sell

3

Hold

4

Buy

5

Strong Buy


The overall quant rating is not an average of the factor grades listed.Instead, it gives greater weight to the metrics with the strongest predictive value.

Growth-Scoring Model Detail

Name

Fatcor
Percentage

Total Revenue Growth Over Prior Year

6.04

Market

58

Sector

57

Gross Profit Growth Over Prior Year

6.66

Market

54

Sector

57

EBITDA Growth Over Prior Year

12.4

Market

68

Sector

66

EBITA Growth Over Prior Year

12.54

Market

67

Sector

59

EBIT Growth Over Prior Year

15.2

Market

70

Sector

60

Earnings from Cont. Ops. Growth Over Prior Year

-91.45

Market

1

Sector

3

Net Income Growth Over Prior Year

-91.53

Market

1

Sector

3

Normalized Net Income Growth Over Prior Year

13.75

Market

68

Sector

53

Diluted EPS before Extra Growth Over Prior Year

-91.56

Market

1

Sector

3

A/R Growth Over Prior Year

-5.15

Market

20

Sector

21

Inventory Growth Over Prior Year

-4.31

Market

22

Sector

19

PPE Net Growth Over Prior Year

0.53

Market

44

Sector

64

Total Assets Growth Over Prior Year

-5.04

Market

14

Sector

39

Tangible Book Value Growth Over Prior Year

0

Market

0

Sector

0

Common Equity Growth Over Prior Year

-15.34

Market

9

Sector

37

Cash from Ops. Growth Over Prior Year

35.2

Market

89

Sector

71

CAPEX Growth Over Prior Year

-10.6

Market

22

Sector

42

Dividend per Share Growth Over Prior Year

2.67

Market

44

Sector

95

Levered Free Cash Flow Growth Over Prior Year

19.68

Market

69

Sector

60

Unlevered Free Cash Flow Growth Over Prior Year

18.62

Market

68

Sector

61

Profitability-Scoring Model Detail

Name

Fatcor
Percentage

Gross Margin %

79

Market

91

Sector

80

SG&A Margin %

20.9

Market

67

Sector

34

EBITDA Margin %

46.8

Market

87

Sector

99

EBITA Margin %

45.5

Market

95

Sector

99

EBIT Margin %

37.2

Market

91

Sector

98

Earnings from Cont. Ops Margin %

1.67

Market

7

Sector

73

Net Income Margin %

1.67

Market

8

Sector

73

Net Income Avail. for Common Margin %

1.67

Market

8

Sector

74

Normalized Net Income Margin %

21.7

Market

91

Sector

97

Levered Free Cash Flow Margin %

35.2

Market

94

Sector

98

Unlevered Free Cash Flow Margin %

37.4

Market

92

Sector

98

Return on Assets %

11.03

Market

84

Sector

96

Return on Capital %

14.07

Market

80

Sector

95

Return on Equity %

2.29

Market

7

Sector

77

Return on Common Equity %

2.28

Market

7

Sector

77

Total Asset Turnover

0.47

Market

47

Sector

61

Sub-Scoring Model

Valuation
Momentum
Growth
Profitability
80
60
40
20
Valuation: 51
Momentum: 88
Growth: 42
Profitability: 60

Valuation-Scoring Model Detail

Name

Fatcor
Percentage

TEV/LTM Total Revenue

5.13

Market

66

Sector

65

TEV/LTM EBITDA

10.84

Market

37

Sector

67

P/LTM Normalized EPS

21.8

Market

33

Sector

38

P/BV

7.01

Market

74

Sector

87

TEV/LTM Unlevered FCF

13.74

Market

17

Sector

60

Momentum-Scoring Model Detail

Name

Fatcor
Percentage

1M Price Performance

-4.49

Market

50

Sector

72

3M Price Performance

19.17

Market

97

Sector

92

6M Price Performance

27.7

Market

98

Sector

89

9M Price Performance

55

Market

99

Sector

94

1Y Price Performance

58

Market

97

Sector

93

Start analyzing Gilead Sciences, Inc. - NASDAQGS:GILD with easy-to-understand research reports

Start analyzing Recent popular companies with easy-to-understand research reports